Mebendazole: The Antiparasitic Drug That Could Beat Lung and Liver Cancer скачать в хорошем качестве

Mebendazole: The Antiparasitic Drug That Could Beat Lung and Liver Cancer

This article explores the repositioning of mebendazole, a well-known antiparasitic drug that has demonstrated significant potential in the treatment of cancer. According to a patent filed by Johns Hopkins University, the drug is capable of blocking cancer cell division and suppressing tumor vessel growth, particularly in lung and liver cancer. Studies confirm that high doses of the drug are well tolerated, but its use in oncology still requires final-stage clinical trials. The key value of this discovery lies in the potential for creating an accessible and effective treatment method, which is already sometimes used by physicians outside of official guidelines. Despite these encouraging findings, the authors caution against self-medication due to the need for strict medical monitoring of liver and blood function. Thus, the article describes the transformation of an old generic drug into a promising tool in modern anticancer medicine.